Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Thoracic Surgery

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 202 articles:
HTML format



Single Articles


    September 2022

  1. Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
    PubMed    


  2. VERGALLO R, Patrono C
    Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected few.
    Eur Heart J. 2022 Sep 14. pii: 6697011. doi: 10.1093.
    PubMed    


  3. HAN Y
    Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement.
    Eur Heart J. 2022 Sep 14. pii: 6697004. doi: 10.1093.
    PubMed    


  4. KO KY, Hong GR, Lee SH
    Novel technique of sutureless pulmonic valve replacement for quadricuspid pulmonic valve with huge pulmonary artery aneurysm.
    Eur Heart J. 2022;43:3183.
    PubMed    


    August 2022
  5. HALVORSEN S, Mehilli J, Cassese S, Hall TS, et al
    2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
    Eur Heart J. 2022 Aug 26. pii: 6675076. doi: 10.1093.
    PubMed    


  6. ZHANG X, Wang H, Guo Y, Peng Y, et al
    Aortic root 'sink down' caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet's disease.
    Eur Heart J. 2022 Aug 18. pii: 6670978. doi: 10.1093.
    PubMed    


  7. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    PubMed    


  8. CREA F
    Challenges in the management of aortic stenosis, multiple valve disease, culture-negative endocarditis, and cardiac surgery during pregnancy.
    Eur Heart J. 2022;43:2715-2719.
    PubMed    


  9. KONG WKF, Salsano A, Giacobbe DR, Popescu BA, et al
    Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry.
    Eur Heart J. 2022;43:2770-2780.
    PubMed     Abstract available


  10. HAHN RT, Pibarot P, Otto CM
    Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
    Eur Heart J. 2022;43:2767-2769.
    PubMed    


  11. ANDREOTTI F, Massetti M, Ten Berg J
    Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.
    Eur Heart J. 2022;43:2798-2800.
    PubMed    


    July 2022
  12. ORTEGA-PAZ L, Angiolillo DJ
    Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention.
    Eur Heart J. 2022 Jul 21. pii: 6647789. doi: 10.1093.
    PubMed    


  13. CREA F
    The challenge of risk stratification in aortic aneurysms, congenital heart disease, and coronary bypass surgery.
    Eur Heart J. 2022;43:2343-2346.
    PubMed    


  14. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    PubMed    


  15. RYCHIK J
    You can only change what you measure: an argument for more detailed characterization in the Fontan circulation.
    Eur Heart J. 2022;43:2385-2387.
    PubMed    


  16. INAI K, Inuzuka R, Ono H, Nii M, et al
    Predictors of long-term mortality among perioperative survivors of Fontan operation.
    Eur Heart J. 2022;43:2373-2384.
    PubMed     Abstract available


    June 2022
  17. VERGALLO R, Volpe M
    The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
    Eur Heart J. 2022 Jun 25. pii: 6617779. doi: 10.1093.
    PubMed    


  18. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    PubMed    


  19. KHAIRY P, Silka MJ, Moore JP, DiNardo JA, et al
    Sudden cardiac death in congenital heart disease.
    Eur Heart J. 2022;43:2103-2115.
    PubMed     Abstract available


  20. HAN Y
    Current clinical data and experience of TAVR in China.
    Eur Heart J. 2022;43:2087-2088.
    PubMed    


  21. BRAUNWALD E
    Cardiac xenotransplantation: a new path for the treatment of advanced heart failure?
    Eur Heart J. 2022 Jun 4. pii: 6601572. doi: 10.1093.
    PubMed    


  22. BELLUSCHI I, Buzzatti N, Denti P, Maisano F, et al
    Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve.
    Eur Heart J. 2022;43:2081.
    PubMed    


    May 2022
  23. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    PubMed     Abstract available


  24. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed     Abstract available


  25. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available


  26. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022;43:1884.
    PubMed    


  27. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022;43:1792-1793.
    PubMed    


  28. VAN STEENBERGEN GJ, Tsang QHY, van der Heijden OWH, Vart P, et al
    Timing of cardiac surgery during pregnancy: a patient-level meta-analysis.
    Eur Heart J. 2022 May 13. pii: 6585605. doi: 10.1093.
    PubMed     Abstract available


  29. BEDEIR K, Robichaux RP, Gleason TG
    Surgical whole valve embolization 15 years after implantation.
    Eur Heart J. 2022;43:1685.
    PubMed    


  30. JANG SJ, Chen YH, Shen TC
    Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
    Eur Heart J. 2022;43:1684.
    PubMed    


    April 2022
  31. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
    Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
    Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
    PubMed     Abstract available


  32. DAYAN V, Gomes WJ
    The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
    Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
    PubMed    


  33. THIELE H, Collet JP, Leon M, Mehran R, et al
    The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
    PubMed    


  34. CRESPO-LEIRO MG, Costanzo MR, Gustafsson F, Khush KK, et al
    Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies.
    Eur Heart J. 2022 Apr 20. pii: 6571226. doi: 10.1093.
    PubMed     Abstract available


  35. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
    Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
    Eur Heart J. 2022;43:1598.
    PubMed    



  36. Corrigendum to: P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Apr 8. pii: 6565204. doi: 10.1093.
    PubMed    


  37. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  38. CREA F
    Percutaneous coronary intervention vs. coronary artery bypass graft: the saga continues.
    Eur Heart J. 2022;43:1273-1276.
    PubMed    


  39. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    PubMed    


  40. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    PubMed    


  41. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  42. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    PubMed    


  43. RUDOLPH V
    Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
    Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
    PubMed    


  44. GIANNITSIS E, Frey N
    Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best.
    Eur Heart J. 2022 Feb 17. pii: 6530230. doi: 10.1093.
    PubMed    


  45. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    PubMed     Abstract available


  46. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
    Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
    Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
    PubMed    


  47. COLOMBO A, Maisano F
    A new tool for the forgotten valve: a score to predict the risk of surgery.
    Eur Heart J. 2022;43:663-665.
    PubMed    


  48. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    PubMed     Abstract available


  49. IUNG B, Urena M
    New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
    Eur Heart J. 2022;0.
    PubMed    


  50. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.
    PubMed    


  51. FENG D, Zhang C, Wang J, Lin B, et al
    Simultaneous transcatheter aortic mitral and tricuspid valve-in-valve implantation.
    Eur Heart J. 2022;43:433.
    PubMed    


  52. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
    Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
    Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  53. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
    PubMed    


  54. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    PubMed     Abstract available


  55. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    PubMed     Abstract available


    December 2021
  56. BENEDETTO U, Dimagli A, Kaura A, Sinha S, et al
    Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit.
    Eur Heart J. 2021;43:44-52.
    PubMed     Abstract available


  57. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    PubMed     Abstract available


  58. BODEN WE, De Caterina R, Taggart DP
    Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility.
    Eur Heart J. 2021;43:68-70.
    PubMed    


  59. BULLUCK H, Thygesen K, Hausenloy DJ
    Prognostically relevant cardiac troponin elevations with percutaneous coronary interventions.
    Eur Heart J. 2021 Dec 21. pii: 6471438. doi: 10.1093.
    PubMed    


  60. ALFONSO F, Rivero F, Segovia-Cubero J
    Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology?
    Eur Heart J. 2021;42:4930-4933.
    PubMed    


  61. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    PubMed    


  62. NAVARESE EP, Andreotti F
    Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes.
    Eur Heart J. 2021;42:4699-4700.
    PubMed    


  63. ABELLAS-SEQUEIROS M, Pardo Sanz A, Sanchez-Recalde A, Sanmartin-Fernandez M, et al
    Traumatic coronary artery dissection with total occlusion of left descending coronary artery: to stent or not to stent.
    Eur Heart J. 2021;42:4701.
    PubMed    


  64. BROWN DL, Boden WE
    Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?
    Eur Heart J. 2021;42:4652-4655.
    PubMed    


    November 2021
  65. BAUMGARTNER H
    Aortic stenosis management in 2021: better teaming up than fighting between specialties.
    Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
    PubMed    


  66. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
    PubMed     Abstract available


  67. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    PubMed    


  68. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    PubMed    


  69. MICHOWITZ Y, Kronborg MB, Glikson M, Nielsen JC, et al
    The '10 commandments' for the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021;42:4295.
    PubMed    


  70. PASQUALIN G, Sturla F, D'Aiello AF, Chessa M, et al
    Mixed reality navigation of a systemic venous baffle obstruction: unravelling the percutaneous approach in atrial switch operation.
    Eur Heart J. 2021;42:4284.
    PubMed    


    October 2021
  71. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
    Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
    Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
    PubMed     Abstract available


  72. ESCANED J, Cao D, Baber U, Nicolas J, et al
    Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
    PubMed     Abstract available


  73. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  74. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
    TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
    Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
    PubMed     Abstract available


  75. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    PubMed    


  76. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
    The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
    Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
    PubMed    


  77. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    PubMed    


  78. ERLINGE D, Gotberg M
    We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?
    Eur Heart J. 2021 Sep 4. pii: 6364082. doi: 10.1093.
    PubMed    


  79. MANCINI D, Gibson GT, Rangasamy S
    Improving survival after heart transplantation despite increasing complexity.
    Eur Heart J. 2021 Sep 3. pii: 6363624. doi: 10.1093.
    PubMed    


  80. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    PubMed    


    August 2021
  81. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    PubMed     Abstract available


  82. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
    2021 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
    PubMed    


  83. GALLI M, Angiolillo DJ
    Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
    Eur Heart J. 2021 Aug 25. pii: 6357340. doi: 10.1093.
    PubMed    


  84. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available


  85. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    PubMed    


  86. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed     Abstract available


  87. TEN BERG J
    Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
    Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
    PubMed    


  88. DANGAS G, Nicolas J, Mehran R
    Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
    Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
    PubMed    


  89. GHAREBAGHI N, Mehdizade H, Askari B, Mirza-Aghazadeh-Attari M, et al
    A bizarre foreign object in the heart: toothpick lodged in the tricuspid valve.
    Eur Heart J. 2021;42:2957.
    PubMed    


  90. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


  91. ZHU Y, Lingala B, Baiocchi M, Toro Arana V, et al
    The Stanford experience of heart transplantation over five decades.
    Eur Heart J. 2021 Aug 1. pii: 6333296. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  92. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed    


  93. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    PubMed     Abstract available


  94. KHARBANDA RK
    Reflective learning on the role of cerebral embolic protection in TAVI patients?
    Eur Heart J. 2021;42:2680-2682.
    PubMed    


  95. MAMAS MA
    Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk.
    Eur Heart J. 2021 Jul 13. pii: 6319849. doi: 10.1093.
    PubMed    


  96. CHESSA M, Brida M, Gatzoulis MA, Diller GP, et al
    Emergency department management of patients with adult congenital heart disease: a consensus paper from the ESC Working Group on Adult Congenital Heart Disease, the European Society for Emergency Medicine (EUSEM), the European Association for Cardio-T
    Eur Heart J. 2021;42:2527-2535.
    PubMed     Abstract available


  97. KITAMURA M, Holzhey D, Thiele H, Abdel-Wahab M, et al
    Single leaflet BASILICA for bilateral coronary artery protection.
    Eur Heart J. 2021;42:2612.
    PubMed    


  98. ONO M, Garg S, Onuma Y, Serruys PW, et al
    Coronary artery bypass grafting versus percutaneous coronary intervention in ischaemic heart failure. Can reliable treatment decisions in high-risk patients be based on non-randomized data?
    Eur Heart J. 2021 Jul 1. pii: 6311994. doi: 10.1093.
    PubMed    


  99. OYETUNJI SO, Otto CM
    Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.
    Eur Heart J. 2021 Jul 1. pii: 6311995. doi: 10.1093.
    PubMed    


    June 2021
  100. JORGENSEN TH, Thyregod HGH, Ihlemann N, Nissen H, et al
    Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
    Eur Heart J. 2021 Jun 28. pii: 6310288. doi: 10.1093.
    PubMed     Abstract available


  101. CREA F
    The Universal Definition of Heart Failure, risk prediction in cardiogenic shock, artificial intelligence in cardiac allograft rejection, and the genetics of dilated cardiomyopathy.
    Eur Heart J. 2021;42:2317-2320.
    PubMed    


  102. VETA M, van Diest PJ, Vink A
    Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis?
    Eur Heart J. 2021;42:2370-2372.
    PubMed    


  103. PEYSTER EG, Arabyarmohammadi S, Janowczyk A, Azarianpour-Esfahani S, et al
    An automated computational image analysis pipeline for histological grading of cardiac allograft rejection.
    Eur Heart J. 2021;42:2356-2369.
    PubMed     Abstract available


  104. GOLIASCH G, Lang IM
    Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
    Eur Heart J. 2021 Jun 13. pii: 6297824. doi: 10.1093.
    PubMed    


    May 2021
  105. BULLUCK H, Paradies V, Barbato E, Baumbach A, et al
    Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardio
    Eur Heart J. 2021 May 31. pii: 6290281. doi: 10.1093.
    PubMed     Abstract available


  106. VOLZ S, Redfors B, Angeras O, Ioanes D, et al
    Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Eur Heart J. 2021 May 23. pii: 6282431. doi: 10.1093.
    PubMed     Abstract available


  107. BIENJONETTI-BOUDREAU D, Fleury MA, Voisine M, Paquin A, et al
    Impact of sex on the management and outcome of aortic stenosis patients.
    Eur Heart J. 2021 May 23. pii: 6282426. doi: 10.1093.
    PubMed     Abstract available


  108. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
    The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
    Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
    PubMed     Abstract available


  109. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
    Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
    PubMed     Abstract available


  110. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  111. LANSKY A, Chun H, Pietras C, Hussain Y, et al
    Refining drug-eluting stent technologies: from engineering to basic science.
    Eur Heart J. 2021;42:1770-1772.
    PubMed    


    April 2021
  112. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
    Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
    Eur Heart J. 2021 Apr 19. pii: 6237954. doi: 10.1093.
    PubMed     Abstract available


  113. BODEN WE, Stone PH
    To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
    Eur Heart J. 2021;42:1394-1400.
    PubMed    


  114. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
    The association between coronary graft patency and clinical status in patients with coronary artery disease.
    Eur Heart J. 2021;42:1433-1441.
    PubMed     Abstract available


  115. DING D, Huang J, Westra J, Cohen DJ, et al
    Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions.
    Eur Heart J. 2021 Apr 5. pii: 6211340. doi: 10.1093.
    PubMed     Abstract available


  116. TEN BERG J, Sibbing D, Rocca B, Van Belle E, et al
    Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in coll
    Eur Heart J. 2021 Apr 5. pii: 6210683. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  117. CREA F
    Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
    Eur Heart J. 2021;42:1185-1189.
    PubMed    


  118. VITALE N, Lucarelli K, Di Bari N, Milano AD, et al
    Anomalous origin of a grafted left internal mammary artery from the deep brachial artery.
    Eur Heart J. 2021;42:1182.
    PubMed    


  119. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
    Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
    Eur Heart J. 2021;42:1019-1034.
    PubMed     Abstract available


  120. REED GW, Krishnaswamy A, Kapadia SR
    Silent brain infarction after TAVR: common but of unclear significance.
    Eur Heart J. 2021;42:1016-1018.
    PubMed    


  121. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
    Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
    Eur Heart J. 2021;42:1051.
    PubMed    


    February 2021
  122. CAO D, Baber U, Mehran R
    Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention.
    Eur Heart J. 2021 Feb 22. pii: 6146039. doi: 10.1093.
    PubMed    


  123. SCHOENRATH F, Just IA, Falk V, Emmert MY, et al
    Antiplatelet and direct oral anticoagulation management after coronary artery bypass graft surgery: the Cinderella of current cardiovascular trials, please show me (some) evidence.
    Eur Heart J. 2021 Feb 22. pii: 6146041. doi: 10.1093.
    PubMed    


  124. CASE BC, Ben-Dor I, Satler LF, Waksman R, et al
    Rescue alcohol septal ablation for dynamic left ventricular outflow tract obstruction and haemodynamic collapse after transcatheter aortic valve implantation.
    Eur Heart J. 2021 Feb 21. pii: 6145857. doi: 10.1093.
    PubMed    


  125. DIAZ-RODRIGUEZ S, Rasser C, Mesnier J, Chevallier P, et al
    Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo.
    Eur Heart J. 2021 Feb 13. pii: 6134553. doi: 10.1093.
    PubMed     Abstract available


  126. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    PubMed    


  127. LIUZZO G, Patrono C
    When less is more: dual antiplatelet therapy in elective percutaneous coronary intervention.
    Eur Heart J. 2021 Feb 8. pii: 6130737. doi: 10.1093.
    PubMed    


  128. CREA F
    Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic.
    Eur Heart J. 2021;42:361-364.
    PubMed    


  129. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  130. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    PubMed     Abstract available


  131. LUNARDI M, Onuma Y, Serruys PW
    Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
    Eur Heart J. 2021 Jan 27. pii: 6121205. doi: 10.1093.
    PubMed    


  132. BERGMARK BA, Morrow DA
    Cardiac troponin elevation after elective PCI: adding infarct to major injury.
    Eur Heart J. 2021;42:335-338.
    PubMed    


  133. QUERCIOLI A, Capettini AC, Gherli R, Secco GG, et al
    Three-dimensional echo guidance of percutaneous mitral paravalvular leak closure.
    Eur Heart J. 2021;42:359.
    PubMed    


  134. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
    First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
    Eur Heart J. 2021;42:357.
    PubMed    


  135. GUPTA A, Chhikara S
    Significant pinching of dominant left circumflex artery during provisional left main bifurcation angioplasty: what next?
    Eur Heart J. 2021;42:285.
    PubMed    


  136. DAVIES A, Fox K, Galassi AR, Banai S, et al
    Management of refractory angina: an update.
    Eur Heart J. 2021;42:269-283.
    PubMed     Abstract available



  137. Corrigendum to: Clinical and Conceptual Approaches to interpreting the findings of Systematic Review and Meta-Analysis of Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
    Eur Heart J. 2021 Jan 17. pii: 6103211. doi: 10.1093/eurheartj/ehaa1092.
    PubMed    


  138. NICHOLLS M
    The Year in Cardiovascular Medicine 2020: Coronary Intervention.
    Eur Heart J. 2021 Jan 17. pii: 6103209. doi: 10.1093/eurheartj/ehaa1021.
    PubMed    


  139. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    PubMed     Abstract available


    December 2020
  140. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed     Abstract available


  141. CORTESE F, Magli M, Di Marino S
    A floating thrombus in the ascending aorta, as a complication of a percutaneous coronary angiography.
    Eur Heart J. 2020 Dec 14. pii: 6034852. doi: 10.1093/eurheartj/ehaa1001.
    PubMed    


  142. CHEN J, Wei L, Wang C
    The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery.
    Eur Heart J. 2020 Dec 12. pii: 6031686. doi: 10.1093.
    PubMed    


  143. GIACOPPO D, Matsuda Y, Fovino LN, D'Amico G, et al
    Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized cl
    Eur Heart J. 2020 Dec 7. pii: 6025040. doi: 10.1093.
    PubMed     Abstract available


  144. GALIUTO L, Patrono C
    Aspirin Monotherapy vs. DAPT after TAVI: Is Less More? Comment on the POPular TAVI Trial.
    Eur Heart J. 2020;41:4301-4302.
    PubMed    


    November 2020
  145. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
    Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
    Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
    PubMed     Abstract available


  146. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
    PubMed    


  147. SHARMA A, Bertog S, Mbai M
    Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation.
    Eur Heart J. 2020 Nov 6. pii: 5959818. doi: 10.1093.
    PubMed    


    October 2020
  148. FANAROFF AC, Lopes RD
    Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy.
    Eur Heart J. 2020 Oct 25. pii: 5939783. doi: 10.1093.
    PubMed    


  149. DREYFUS G, Windecker S
    How to shape the future of cardiology and cardiac surgery?
    Eur Heart J. 2020 Oct 16. pii: 5925735. doi: 10.1093.
    PubMed    


  150. CHEN SL
    In the face of cunning enemy: DK crush writes legend.
    Eur Heart J. 2020;41:3763-3764.
    PubMed    


  151. BABER U, Dangas G, Angiolillo DJ, Cohen DJ, et al
    Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
    Eur Heart J. 2020;41:3533-3545.
    PubMed     Abstract available


    September 2020
  152. DREYFUS J, Flagiello M, Bazire B, Eggenspieler F, et al
    Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes.
    Eur Heart J. 2020 Sep 25. pii: 5911419. doi: 10.1093.
    PubMed     Abstract available


  153. BAUMGARTNER H, Iung B, Otto CM
    Timing of intervention in asymptomatic patients with valvular heart disease.
    Eur Heart J. 2020 Sep 9. pii: 5903163. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  154. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  155. RIMAC G, Marzouk M, Dumont E, Paradis JM, et al
    When a delayed cardiology consultation leads to a massive left ventricle pseudoaneurysm: collateral effects of the COVID-19 pandemic.
    Eur Heart J. 2020;41:3102.
    PubMed    


  156. TARANTINI G, Cardaioli F, Pavei A, Fabris T, et al
    Unfolding of unexpected and extreme transcatheter aortic valve distortion.
    Eur Heart J. 2020 Aug 18. pii: 5893662. doi: 10.1093.
    PubMed    


  157. MOHTY D, Pibarot P, Damy T
    Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'.
    Eur Heart J. 2020;41:2815.
    PubMed    


  158. BAUMGARTNER H
    Transcatheter valve-in-valve implantation in failed aortic bioprosthetic valves: a word of caution in times of euphoria.
    Eur Heart J. 2020;41:2743-2746.
    PubMed    


  159. LUSCHER TF
    Frontiers in valvular heart disease: outcomes of novel percutaneous procedures.
    Eur Heart J. 2020;41:2717-2720.
    PubMed    


    July 2020
  160. GILMANOV D, Greco C, Cafaro A, Zaccaria S, et al
    Two coronary artery aneurysms complicated by acute myocardial infarction and treated with open chest surgery.
    Eur Heart J. 2020 Jul 29. pii: 5877568. doi: 10.1093.
    PubMed    


  161. HOWARD JP, Arnold AD, Ahmad Y
    Bias, heterogeneity, and uncertainty in meta-analysis.
    Eur Heart J. 2020;41:2712.
    PubMed    


  162. FALK RH, Dorbala S
    Transthyretin cardiac amyloidosis in patients with severe aortic stenosis.
    Eur Heart J. 2020 Jul 8. pii: 5868579. doi: 10.1093.
    PubMed    


    June 2020
  163. ROMMEL KP, Lurz P
    Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
    Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
    PubMed    


  164. D'ALTO M, Naeije R
    Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
    Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
    PubMed    


  165. BLEIZIFFER S, Simonato M, Webb JG, Rodes-Cabau J, et al
    Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.
    Eur Heart J. 2020 Jun 27. pii: 5863929. doi: 10.1093.
    PubMed     Abstract available


  166. VARELA-CANCELO A, Salgado-Fernandez J, Calvino-Santos R, Bouzas-Zubeldia B, et al
    Successful transfemoral management of transcatheter aortic valve embolization into left ventricle.
    Eur Heart J. 2020 Jun 4. pii: 5851539. doi: 10.1093.
    PubMed    


    May 2020
  167. WEBB J, Wood D, Sathananthan J, Landes U, et al
    Balloon-expandable or self-expandable transcatheter heart valves. Which are best?
    Eur Heart J. 2020;41:1900-1902.
    PubMed    


  168. GAUDINO M, Freemantle N, Farkouh ME
    The conundrum of the treatment for left main coronary disease.
    Eur Heart J. 2020 May 5. pii: 5830808. doi: 10.1093.
    PubMed    


  169. BJORNSTAD JL, Bendz B
    Periprocedural myocardial injury in the EXCEL trial.
    Eur Heart J. 2020;41:1703.
    PubMed    


    April 2020
  170. CHEN Y, Waksman R, Satler L, Barnett C, et al
    Percutaneous transcatheter release of stuck mechanical mitral valve leaflet.
    Eur Heart J. 2020 Apr 20. pii: 5822833. doi: 10.1093.
    PubMed    


  171. MURAKAMI T, Ohno Y, Nakazawa G, Ikari Y, et al
    Transjugular intracardiac echocardiography-guided transcatheter aortic valve implantation.
    Eur Heart J. 2020 Apr 14. pii: 5819673. doi: 10.1093.
    PubMed    


  172. SCULLY PR, Patel KP, Treibel TA, Thornton GD, et al
    Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
    Eur Heart J. 2020 Apr 8. pii: 5817909. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  173. STONE GW, Ben-Yehuda O, Sabik JF, Kappetein AP, et al
    Considerations for an optimal definition of procedural myocardial infarction.
    Eur Heart J. 2020 Mar 30. pii: 5813684. doi: 10.1093.
    PubMed    


  174. KONG WKF, Bax JJ, Delgado V
    Left ventricular myocardial fibrosis: a marker of bad prognosis in symptomatic severe aortic stenosis.
    Eur Heart J. 2020 Mar 24. pii: 5811373. doi: 10.1093.
    PubMed    


  175. LURZ P, Orban M, Besler C, Braun D, et al
    Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.
    Eur Heart J. 2020 Mar 16. pii: 5807655. doi: 10.1093.
    PubMed     Abstract available


  176. ALVAREZ-COVARRUBIAS HA, Xhepa E, Michel JM, Kasel AM, et al
    1000 mm2 plus aortic annulus: successful treatment of a giant bicuspid aortic valve with a Sapien 3 transcatheter heart valve.
    Eur Heart J. 2020 Mar 10. pii: 5802606. doi: 10.1093.
    PubMed    


  177. SCHMIADY MO, Taramasso M, Maisano F, Sigler M, et al
    Mitral valve surgery after MitraClip(R) implantation: what histopathology can tell us?
    Eur Heart J. 2020 Mar 6. pii: 5788531. doi: 10.1093.
    PubMed    


    February 2020
  178. JERING KS, Pfeffer MA
    From practice changing to hypothesis generating: a virtuous cycle.
    Eur Heart J. 2020;41:955-957.
    PubMed    


  179. KHOR L, Simmons LA, Von Bardeleben RS, Ng MK, et al
    Transcatheter edge-to-edge repair for tricuspid regurgitation in Barlow-type tricuspid valve prolapse.
    Eur Heart J. 2020 Feb 20. pii: 5741384. doi: 10.1093.
    PubMed    


  180. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
    Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.
    Eur Heart J. 2020 Feb 12. pii: 5734668. doi: 10.1093.
    PubMed     Abstract available


  181. PULS M, Beuthner BE, Topci R, Vogelgesang A, et al
    Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis.
    Eur Heart J. 2020 Feb 12. pii: 5734676. doi: 10.1093.
    PubMed     Abstract available


  182. HAMM CW, Beyersdorf F
    GARY-The Largest Registry of Aortic Stenosis Treatment Worldwide.
    Eur Heart J. 2020;41:733-735.
    PubMed    


    January 2020
  183. AUFFRET V, Puri R, Leurent G, Le Breton H, et al
    Conduction disturbances following trancatheter aortic valve implantation: increasing the 'pace' towards prospective evidence.
    Eur Heart J. 2020 Jan 20. pii: 5710689. doi: 10.1093.
    PubMed    


  184. OZKAN J
    Bernhard Meier MD FACC FESC.
    Eur Heart J. 2020;41:340-342.
    PubMed    


  185. SONDERGAARD L
    Durability of transcatheter bioprosthetic aortic valves.
    Eur Heart J. 2020 Jan 6. pii: 5697053. doi: 10.1093.
    PubMed    


    December 2019
  186. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
    Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
    PubMed     Abstract available


  187. YERASI C, O'Donoghue S, Satler LF, Waksman R, et al
    Apple Watch detecting high-grade block after transcatheter aortic valve implantation.
    Eur Heart J. 2019 Dec 3. pii: 5651110. doi: 10.1093.
    PubMed    


    November 2019
  188. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
    Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
    Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
    PubMed    


  189. RUMPF PM, Michel JM, Xhepa E, Kasel AM, et al
    Paravalvular leakage due to ring dehiscence after mitral valve-in-ring therapy: mechanisms and percutaneous treatment.
    Eur Heart J. 2019 Nov 5. pii: 5613227. doi: 10.1093.
    PubMed    


    October 2019
  190. LIN AE, Libby P, Ebert BL
    A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis.
    Eur Heart J. 2019 Oct 21. pii: 5601845. doi: 10.1093.
    PubMed    


    September 2019
  191. MAS-PEIRO S, Hoffmann J, Fichtlscherer S, Dorsheimer L, et al
    Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation.
    Eur Heart J. 2019 Sep 3. pii: 5554424. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  192. BJURSTEN H, Rasmussen M, Nozohoor S, Gotberg M, et al
    Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.
    Eur Heart J. 2019 Aug 21. pii: 5552575. doi: 10.1093.
    PubMed     Abstract available


  193. ALKHOULI M, Alqahtani F, Ziada KM, Aljohani S, et al
    Contemporary trends in the management of aortic stenosis in the USA.
    Eur Heart J. 2019 Aug 13. pii: 5549415. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  194. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


    May 2019
  195. ARBEL Y, Ben-Assa E, Puzhevsky D, Litmanowicz B, et al
    Forced diuresis with matched hydration during transcatheter aortic valve implantation for Reducing Acute Kidney Injury: a randomized, sham-controlled study (REDUCE-AKI).
    Eur Heart J. 2019 May 23. pii: 5497106. doi: 10.1093.
    PubMed     Abstract available


  196. PETRUS AHJ, Dekkers OM, Tops LF, Timmer E, et al
    Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes.
    Eur Heart J. 2019 May 21. pii: 5494552. doi: 10.1093.
    PubMed     Abstract available


  197. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  198. KASPRZAK JD, Pawlowski J, Peruga JZ, Kaminski J, et al
    First-in-man experience with real-time holographic mixed reality display of three-dimensional echocardiography during structural intervention: balloon mitral commissurotomy.
    Eur Heart J. 2019 Apr 12. pii: 5449042. doi: 10.1093.
    PubMed    


    March 2019
  199. PIAYDA K, Veulemans V, Kelm M, Zeus T, et al
    Transcaval aortic valve implantation through a partially thrombosed infrarenal aortic aneurysm.
    Eur Heart J. 2019 Mar 27. pii: 5420568. doi: 10.1093.
    PubMed    


  200. MIURA M, Gavazzoni M, Taramasso M, Maisano F, et al
    Recurrent tricuspid regurgitation due to valve migration after transcatheter tricuspid valve replacement.
    Eur Heart J. 2019 Mar 20. pii: 5416181. doi: 10.1093.
    PubMed    


    October 2018
  201. MIURA M, Cuevas O, Taramasso M, Maisano F, et al
    Early recurrent mitral regurgitation due to MitraClip migration.
    Eur Heart J. 2018 Oct 4. pii: 5115407. doi: 10.1093.
    PubMed    


    August 2018
  202. BARTEL T, Khalil M, Traina M, Mihaljevic T, et al
    Percutaneous mitral annuloplasty complements clip implantation in functional mitral regurgitation.
    Eur Heart J. 2018 Aug 22. pii: 5078168. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: